Phil Franchina, Author at American Parkinson Disease Association

Creating Connections

Posted on October 1, 2019October 16, 2019 by Phil Franchina

Beyond the Doctor’s Visit: Taking Parkinson’s Care to the Next Level “Game changing.” That’s how Robin...see more Kornhaber, Senior Vice President, National Programs and Partnerships at the American Parkinson Disease Association (APDA), describes APDA Information and Referral (I&R) Centers. APDA I&R Centers are at medical institutions across the country where APDA supports either […]

Taking Parkinson’s education to the farmers market: educating under-served communities

Posted on September 16, 2019April 24, 2024 by Phil Franchina

Dr. Lynda Nwabuobi, Movement Disorder Fellow at Columbia Presbyterian...see more Medical Center in New York City, attended APDA’s Diversity in Parkinson’s Disease (PD) Research Conference in May and was inspired. Dr. Nwabuobi had just spent the day learning about health care disparities in PD care, low […]

THE AMERICAN PARKINSON DISEASE ASSOCIATION AWARDS FRESH CROP OF RESEARCH GRANTS & NEW DIVERSITY-FOCUSED RESEARCH INITIATIVE

Posted on September 5, 2019September 4, 2019 by Phil Franchina

The American Parkinson Disease Association Awards Fresh Crop of Research Grants & New Diversity-Focused Research Initiative From T cells...see more to genetics, $1.7 million in innovative research to be funded for 2019 – 2020 year NEW YORK, NY – September 5, 2019 – The American Parkinson Disease Association (APDA) has just awarded $1.7 million to support […]

APDA DIVERSITY IN PD RESEARCH GRANT: ACADEMIC YEAR 2022-2023

Posted on September 4, 2019 by Phil Franchina

Deadline: 03/11/2022 APPLY HERE Award details One year grant up to a maximum of $75,000 will be awarded to...see more research scientist (MD, MD/PhD, or PhD). The applicants will receive notification of the decision in July 2022. The APDA grant year runs from September 1st to August 31st. Goal APDA Diversity in PD Research Grant is […]

New medication, Istradefylline, gets approved for Parkinson’s disease

Posted on September 4, 2019July 13, 2023 by Phil Franchina

On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval...see more for Istradefylline, a new medication for Parkinson’s disease (PD) to be used as an add-on treatment to carbidopa/levodopa for those experiencing OFF episodes. (For more information on OFF periods in PD, please see this recent APDA […]

APDA Seed Funding Leads to Prestigious NIH Research Grant

Posted on August 16, 2019July 13, 2023 by Phil Franchina

APDA is exceptionally proud to congratulate Dr. Beom-Chan Lee, APDA Research...see more Grant awardee on receiving a recently-awarded National Institutes of Health (NIH) R21 grant.

APDA-funded research finds new role for alpha-synuclein

Posted on July 30, 2019July 13, 2023 by Phil Franchina

This new understanding of alpha-synuclein’s function could open up new ways of thinking...see more about treatments for Parkinson's disease.

Merck announces its decision to stop the manufacturing of Sinemet CR

Posted on July 17, 2019July 30, 2019 by Phil Franchina

Merck has informed the Food and Drug Administration (FDA)...see more that it will discontinue the manufacturing of Sinemet CR (controlled release).

Bill Rasmussen, founder of ESPN, diagnosed with Parkinson’s disease

Posted on July 15, 2019 by Phil Franchina

Bill Rasmussen, founder of ESPN, shares his Parkinson's disease diagnoses.

AMERICAN PARKINSON DISEASE ASSOCIATION CONVENES EXPERTS TO DETERMINE PARKINSON’S DISEASE RESEARCH FUNDING AND TACKLE LACK OF DIVERSITY

Posted on May 21, 2019May 28, 2019 by Phil Franchina

APDA Hosts...see more Top Scientists, Researchers and Neurologists for Two Days to Evaluate Research Projects Vying for Funding and Address Lack of Diversity in PD Research & Care NEW YORK, NY, May 21, 2019 – For two days, the […]

What is Parkinson’s Disease?

Living with Parkinson’s Disease

Parkinson’s Resource Library

Research

Ways to Give

Creating Connections

Taking Parkinson’s education to the farmers market: educating under-served communities

THE AMERICAN PARKINSON DISEASE ASSOCIATION AWARDS FRESH CROP OF RESEARCH GRANTS & NEW DIVERSITY-FOCUSED RESEARCH INITIATIVE

APDA DIVERSITY IN PD RESEARCH GRANT: ACADEMIC YEAR 2022-2023

New medication, Istradefylline, gets approved for Parkinson’s disease

APDA Seed Funding Leads to Prestigious NIH Research Grant

APDA-funded research finds new role for alpha-synuclein

Merck announces its decision to stop the manufacturing of Sinemet CR

Bill Rasmussen, founder of ESPN, diagnosed with Parkinson’s disease

AMERICAN PARKINSON DISEASE ASSOCIATION CONVENES EXPERTS TO DETERMINE PARKINSON’S DISEASE RESEARCH FUNDING AND TACKLE LACK OF DIVERSITY

Wearable Devices for Parkinson’s Disease: The Future Is Here

Food as Medicine: Diet’s Role in Parkinson’s Disease

APDA awards $2.6M to support Parkinson’s research projects

Parkinson’s Disease: Advances in Diagnosis and Treatment

Making Hope Possible: American Parkinson Disease Association Supports Researchers With $2.6 Million in New Funding

AMERICAN PARKINSON DISEASE ASSOCIATION CELEBRATES THE NATIONAL PLAN TO END PARKINSON'S ACT BECOMING LAW

AMERICAN PARKINSON DISEASE ASSOCIATION ANNOUNCES NEW RESOURCES AVAILABLE IN MANDARIN & SIMPLIFIED CHINESE

AMERICAN PARKINSON DISEASE ASSOCIATION TO CELEBRATE THE POWER OF A SUPPORTIVE COMMUNITY DURING PARKINSON’S DISEASE AWARENESS MONTH

EPA Bans TCE, a Solvent Linked to PD

Vyalev: A Newly-Approved Medication for Parkinson’s Disease Motor Fluctuations

Adaptive DBS – a new approach to improve PD symptoms

Recently published research on induced pluripotent stem cells by APDA-funded researchers

Support Our Mission

Support Our Mission

Subscribe to get updates from APDA and helpful Parkinson’s info!